Researchers from the MIGAL Galilee Research Institute (Qiryat Shemona, Israel) are just days away from finishing the production of the active component for a coronavirus vaccine that could be tested on humans by as soon as June 1. The pre-clinical trials have been carried out at the Volcani Institute.
